The Global Gene Therapies Market is poised for exceptional growth through 2032, spurred by advancements in viral and non‑viral vectors, CRISPR and RNA editing technologies, and expanding clinical approvals in neurology and oncology. Neurology leads application share—especially therapies treating rare disorders like beta-thalassemia, sickle cell disease, and hemophilia—while oncology a... https://www.uniprismmarketresearch.com/verticals/healthcare/gene-therapies